GLP-1 Use Reaches Record High as Access Broadens, New Data Shows – NaturalNews.com
The share of Americans using glucagon-like peptide-1 (GLP-1) receptor agonists for weight loss has surged to unprecedented levels, according to reports on rising demand and market forecasts. A new analysis from Goldman Sachs projects the global anti-